Trial
NCT02038478
Allograft for Sickle Cell Disease and Thalassemia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Sickle Cell Disease and Thalassemia
Intervention
Donor Stem Cell Transplantation
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-29